Harbor Investment Advisory’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.12K Hold
756
﹤0.01% 1084
2026
Q1
$6.15K Hold
756
﹤0.01% 991
2025
Q4
$5.08K Hold
756
﹤0.01% 1051
2025
Q3
$6.55K Hold
756
﹤0.01% 971
2025
Q2
$4.76K Hold
756
﹤0.01% 1002
2025
Q1
$4.85K Hold
756
﹤0.01% 980
2024
Q4
$6.08K Hold
756
﹤0.01% 952
2024
Q3
$9.55K Sell
756
-7
-0.9% -$90 ﹤0.01% 876
2024
Q2
$9.66K Hold
763
﹤0.01% 865
2024
Q1
$3.65K Hold
763
﹤0.01% 1017
2023
Q4
$3.66K Buy
763
+51
+7% +$312 ﹤0.01% 983
2023
Q3
$5.16K Hold
712
﹤0.01% 910
2023
Q2
$5.29K Hold
712
﹤0.01% 1120
2023
Q1
$4.93K Hold
712
﹤0.01% 1134
2022
Q4
$7.32K Hold
712
﹤0.01% 1058
2022
Q3
$13K Hold
712
﹤0.01% 999
2022
Q2
$37K Hold
712
0.01% 779
2022
Q1
$52K Hold
712
0.01% 739
2021
Q4
$102K Sell
712
-150
-17% -$25.8K 0.01% 527
2021
Q3
$179K Hold
862
0.02% 390
2021
Q2
$183K Buy
862
+150
+21% +$27.5K 0.02% 386
2021
Q1
$129K Hold
712
0.02% 425
2020
Q4
$79K Buy
712
+317
+80% +$33.7K 0.01% 503
2020
Q3
$43K Buy
395
+245
+163% +$29.8K 0.01% 542
2020
Q2
$13K Buy
+150
New +$5.74K ﹤0.01% 734

Other funds holding NVAX

Harbor Investment Advisory's NVAX Position: Q2 2026 in Review

Harbor Investment Advisory held its Novavax (NVAX) position steady in Q2 2026 at 756 shares worth $7.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

Harbor Investment Advisory first reported a position in NVAX in Q2 2020 and has held it in 25 quarters since. The position peaked at $183K in Q2 2021. 52 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Harbor Investment Advisory held 756 shares of Novavax worth $7.12K as of Q2 2026.
  • Harbor Investment Advisory left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1084 holding.
  • Harbor Investment Advisory first reported a position in Novavax in Q2 2020 and has held it in 25 quarters since.
  • Harbor Investment Advisory's Novavax position peaked at $183K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.